This week from Drug Target Review...

EDITOR'S PICK

Are we on our way to a one-time treatment for HIV?

Researchers have developed a new technology that could offer treatment for HIV infection through a single injection.

READ MORE

TRENDING THIS WEEK

Scientists develop nanoparticles that can cross the blood-brain barrier

Tested using a new brain tissue model, researchers have developed nanoparticles which may be able to deliver chemotherapy drugs for glioblastoma.

Immune protein may contribute to alcoholism relapse

Scientists have found that an immune protein, CSF1, may cause anxiety during alcohol withdrawal, therefore causing relapse.

New insights into how genetic factors affect body’s immune response in type 1 diabetes

The new study highlights 11 genes which could be considered as potential candidates for novel therapeutics for type 1 diabetes.

Three distinct brain circuits in the thalamus contribute to Parkinson’s symptoms

Targeting these brain circuits could offer a new way to reverse motor dysfunction and depression in Parkinson’s disease patients.

Novel CRISPR screen revealed loss of genes in the interferon gamma receptor signalling pathway

A new study has highlighted that the interferon gamma receptor pathway is necessary for CAR T-cell mediated killing in solid tumours.

WHAT TO LISTEN TO

Tune in to our podcast series on the latest information in the drug discovery industry, from cell line development to SARS-CoV-2 variants - and everything in between!

LISTEN NOW

Follow us on?Spotify,?Apple?and?Google?to be the first to know when a new episode is published!

JOIN THE COMMUNITY

Sign up to our?FREE?journal?for information on the drug discovery industry; promoting the latest research and developments, funding projects, and cutting-edge technological developments, as well as access to:

• Quarterly issues in print or digital format
• Breaking news and features on our website
• Case studies, whitepapers, webinars and industry-leading content
• Our extensive online archive of thousands of articles and past issues.

SUBSCRIBE FREE TODAY

Want to keep up to date with our latest content? Follow us on?Want to keep up to date with our latest content? Follow us on?LinkedIn,?Facebook,?Twitter?and?YouTube.